Skip to main content
Equibles

Stephen Hoge

Moderna, Inc. (MRNA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Moderna, Inc. publishes a filing, an earnings call transcript or a press release.

Get MRNA alerts

About Stephen Hoge

The proxy statement of Moderna, Inc. reports total compensation of $18,054,133 for Stephen Hoge in fiscal 2025, including a base salary of $1,260,000. Disclosed compensation is on record for 9 fiscal years. Stephen Hoge has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Moderna, Inc. on November 6, 2026. Moderna, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Moderna, Inc. includes Stéphane Bancel (CEO and Board Member), Noubar Afeyan (Chairman and Board Member), David W. Meline (CFO) and 7 others.

Stephen Hoge on recent calls

“I'll now take you through our recent business updates. As a reminder, slide 12 outlines our multi-year revenue growth strategy, which continues to be anchored in two key drivers, geographic expansion and portfolio expansion through continued pipeline advancement.”
Other, Moderna Third Quarter 2026 Conference Call ·
“So, look, we're obviously thrilled by the results that were announced.”
Other, Morgan Stanley 24th Annual Global Healthcare Conference ·
“Today, I'll take you through our recent business updates. Slide 13 outlines our multi-year revenue growth strategy, anchored in geographic expansion and portfolio expansion from the continued advancement of our product pipeline.”
Other, Moderna Q2 Earnings call ·
“Today I'll review our commercial outlook as well as progress across our pipeline. Slide 11 outlines our multi-year revenue growth strategy, anchored in both geographic expansion and continued advancement of our product pipeline.”
Other, Moderna, Inc. Q1 FY2026 Earnings Call ·
“Today, I'll review our commercial outlook as well as progress across our pipeline. As Jamie mentioned earlier, we expect 2026 to mark a return to revenue growth for Moderna.”
Other, Moderna, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Moderna, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Moderna, Inc. (MRNA) $1,260,000 $18,054,133
2024 Moderna, Inc. (MRNA) $1,083,923 $9,181,478
2023 Moderna, Inc. (MRNA) $1,042,308 $7,339,166
2022 Moderna, Inc. (MRNA) $953,846 $8,646,652
2021 Moderna, Inc. (MRNA) $684,808 $7,803,432
2020 Moderna, Inc. (MRNA) $617,366 $5,263,296
2019 Moderna, Inc. (MRNA) $595,724 $5,001,214
2018 Moderna, Inc. (MRNA) $570,004 $4,726,274
2017 Moderna, Inc. (MRNA) $542,308 $23,951,977

Recent activity